Dr. Eric Berg DC · 2026-05-05 · Eric Berg (host)

The #1 Magnesium Mistake Everyone Makes

15 research-tied claims examined: 2 contradicted 1 overstated 1 context 7 supported 4 unverified

2

Contradicted by research

0:05:08Eric Berg (host)contradictedmoderate

The glycinate component of magnesium glycinate increases GABA to help calm the nervous system and promote sleep.

"magnesium glycinate comes with the glycinate part, which actually helps calm down the nervous system. It helps increase something called GABA, which actually can help you sleep a little bit better." (said at 0:05:08)

The speaker bundles two claims regarding the glycinate (glycine) component of magnesium glycinate: that it promotes calming/sleep, and that it works by increasing GABA. 1. Glycine and sleep: Supported. Clinical trials and animal models indicate that oral glycine supplementation can improve subjective sleep quality and promote sleep, in part by lowering core body temperature via actions on NMDA receptors in the suprachiasmatic nucleus, as well as providing inhibitory neurotransmission. 2. Glycine increasing GABA: Contradicted. Glycine does not act by increasing gamma-aminobutyric acid (GABA). Instead, glycine is itself an independent primary inhibitory neurotransmitter in the central nervous system that acts directly at its own glycine receptors (GlyRs) and serves as an NMDA receptor co-agonist. GABA and glycine represent two distinct inhibitory neurotransmitter systems.

0:13:02Eric Berg (host)contradictedmoderate

Sixty percent of depression cases today are classified as treatment resistant.

"60% of depression nowadays is classified as treatment resistant. Okay? Because the drugs don't work." (said at 0:13:02)

The claim that 60% of depression cases are classified as treatment-resistant is contradicted by epidemiological evidence. Treatment-resistant depression (TRD)—typically defined as a lack of clinically meaningful response after at least two adequate trials of different antidepressants—is estimated to occur in approximately 30% (not 60%) of patients treated for major depressive disorder.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.